Signal Transduction Pathways

Core Concept

Signal transduction is the chain of molecular events that converts an extracellular ligand-binding event into a specific intracellular response. Reception at the receptor triggers a relay of intracellular messengers and enzymes that typically amplifies a tiny signal into a large response and then terminates so the cell can reset. The same general logic — a signal in, a cascade of relays, a response out — underlies nearly all cellular communication.

Key Concepts

Reception, transduction, response

Reception is ligand binding to a receptor and the receptor's resulting shape change. Transduction is the relay of the message through the cell, often by a chain of protein interactions (the "signal transduction pathway"). Response is the final cellular action — a change in enzyme activity, gene expression, ion flux, or cell behavior. Most receptors are cell-surface receptors; hydrophobic ligands (steroids) use intracellular receptors that act directly as transcription regulators.

G protein–coupled receptors (GPCRs)

GPCRs are the largest receptor family. A GPCR spans the membrane seven times. Ligand binding changes its shape so it activates an associated G protein by causing it to exchange bound GDP for GTP. The active G protein then activates an effector enzyme (often adenylyl cyclase). GPCRs mediate vision, smell, taste, and the actions of many hormones and neurotransmitters; roughly a third of all drugs target GPCRs.

Receptor tyrosine kinases (RTKs)

RTKs are membrane receptors with intracellular kinase domains. Ligand binding causes two receptors to pair (dimerize) and phosphorylate each other's tyrosines. Those phosphotyrosines serve as docking sites for relay proteins, which then pass the signal along. RTKs mediate most growth-factor signaling; overactive RTKs drive many cancers.

Ligand-gated ion channels

These receptors are channels that open when a ligand binds, letting specific ions (e.g., Na⁺, K⁺, Ca²⁺) flow across the membrane. The resulting change in membrane potential is itself the signal — this is how neurotransmitters excite or inhibit neurons and how muscle cells are triggered to contract.

Intracellular receptors

Small hydrophobic ligands (steroid hormones, thyroid hormone) diffuse through the plasma membrane and bind receptors in the cytoplasm or nucleus. The ligand–receptor complex acts as a transcription factor, binding DNA to turn specific genes on or off. This produces slower but longer-lasting responses than membrane receptors.

Second messengers

Second messengers are small, non-protein molecules or ions that rapidly relay and amplify the signal inside the cell. cAMP (made from ATP by adenylyl cyclase) and Ca²⁺ are the two most important. Inositol trisphosphate (IP₃) triggers release of Ca²⁺ from the endoplasmic reticulum. Because one activated enzyme can generate many second-messenger molecules, second messengers are major amplification steps.

Phosphorylation cascades

Kinases and phosphatases act as on/off switches. A protein kinase transfers a phosphate from ATP to a protein; a protein phosphatase removes it. In a phosphorylation cascade, one activated kinase phosphorylates many copies of the next kinase, which phosphorylate many more of the next, and so on — each step multiplies the signal. MAP kinase cascades (important in growth and stress responses) are a textbook example.

How It Works

Consider the epinephrine (adrenaline) → cAMP pathway. Epinephrine binds a GPCR (reception). The receptor activates a G protein, which activates adenylyl cyclase, which converts ATP into cAMP (transduction). cAMP activates protein kinase A (PKA), which phosphorylates and activates downstream enzymes. In a liver cell this ultimately activates glycogen phosphorylase, which breaks down glycogen to release glucose — the "fight-or-flight" fuel response. A single epinephrine molecule can trigger synthesis of many cAMP molecules, each activating many PKA molecules, each phosphorylating many target enzymes, so one ligand yields an enormous, fast response — amplification. The pathway is terminated when phosphodiesterase breaks down cAMP and phosphatases remove the phosphates, returning the cell to its resting state.

How it works

Consider the epinephrine (adrenaline) → cAMP pathway. Epinephrine binds a GPCR (reception). The receptor activates a G protein, which activates adenylyl cyclase, which converts ATP into cAMP (transduction). cAMP activates protein kinase A (PKA), which phosphorylates and activates downstream enzymes. In a liver cell this ultimately activates glycogen phosphorylase, which breaks down glycogen to release glucose — the "fight-or-flight" fuel response. A single epinephrine molecule can trigger synthesis of many cAMP molecules, each activating many PKA molecules, each phosphorylating many target enzymes, so one ligand yields an enormous, fast response — amplification. The pathway is terminated when phosphodiesterase breaks down cAMP and phosphatases remove the phosphates, returning the cell to its resting state.

Common confusions

• "The ligand enters the cell to start transduction." Usually wrong — most ligands bind cell-surface receptors and never enter. Only hydrophobic ligands (steroids) enter and bind intracellular receptors.
• "G proteins are the same as GPCRs." Wrong — the GPCR is the receptor; the G protein is a separate relay protein the receptor activates.
• "cAMP and Ca²⁺ are enzymes." Wrong — they are small second-messenger molecules/ions, not enzymes.
• "Kinases add phosphates randomly." Wrong — kinases phosphorylate specific residues (serine, threonine, or tyrosine) on specific target proteins; this specificity is what makes cascades orderly.
• "Amplification means the ligand is copied." Wrong — the ligand is not copied; downstream enzymes each make many product molecules, multiplying the signal's strength.

Quick review

• Signal transduction = reception → transduction → response.
• Four receptor types: GPCR, RTK, ligand-gated ion channel, intracellular receptor.
• GPCRs use G proteins and often cAMP; RTKs use tyrosine autophosphorylation.
• cAMP and Ca²⁺ are the major second messengers; both amplify the signal.
• Phosphorylation cascades (kinases add P, phosphatases remove P) multiply the signal at each step.
• Amplification lets one ligand produce a large cellular response.
• Termination via phosphodiesterase and phosphatases resets the pathway.